Suzuken Co (9987.T) Osake Kurssi
Suzuken Co Kurssi
Viimeisten 19 vuoden aikana Suzuken Con liikevaihto kasvoi 2,9 % vuodessa ja ylsi 2,49 T JPY:een. Osakekohtainen tulos on kasvanut 4,1 % vuodessa viimeisten 19 vuoden aikana. Suzuken Con nettomarginaali 1,5 % on pääosin vakaa verrattuna 0,6 %:iin muutama vuosi sitten. Nykyhinnalla osinkotuotto on noin 2,59 %. Jakosuhde on noin 25 % tuloksesta. Osinko on kasvanut 6,8 % vuodessa viimeisten 19 vuoden aikana. Suzuken Con 12 kuukauden konsensustavoitehinta on 6 436,20 JPY, noin yli kurssia 122,1 %. 8 analyytikosta 4 suosittaa ostoa — kokonaiskonsensus on Osta.
Suzuken Co osakekurssi
Hae nämä tiedot Eulerpool API:n kautta
100 000 pyyntöä/kk ilmaiseksi · ei luottokorttia
Suzuken Co liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset Suzuken Co -osakkeesta
The business model of Suzuken Co Ltd revolves around the distribution and sales of pharmaceutical and medical products in Japan. As a leading company in the healthcare industry, Suzuken operates through various segments including Pharmaceutical Wholesale, Pharmacy Chain, Medical Instruments and Equipment, and Home Healthcare. Suzuken collaborates with manufacturers to procure and distribute a wide range of pharmaceutical products to hospitals, clinics, and pharmacies across Japan. The company aims to enhance healthcare accessibility by providing high-quality medical supplies and services to customers. Suzuken's comprehensive business model enables it to contribute effectively to the healthcare system and meet the evolving needs of the Japanese market.
Suzuken Co Ltd is primarily active in the pharmaceutical industry.
The main competitors of Suzuken Co Ltd in the market include McKesson Corporation, AmerisourceBergen Corporation, and Cardinal Health Inc. These companies are global pharmaceutical wholesale distributors that operate in a similar industry as Suzuken. McKesson Corporation, based in the United States, is one of the largest healthcare services and information technology companies. AmerisourceBergen Corporation, also based in the United States, is a leading provider of pharmaceutical distribution and related healthcare services. Cardinal Health Inc. is another prominent player in the healthcare services and products sector, with operations in over 60 countries.
Suzuken Co Ltd is a renowned Japanese company with a rich history and background. Established in 1921, Suzuken initially operated as a wholesale distributor for pharmaceutical products. Over the years, the company expanded its operations and diversified its portfolio. Today, Suzuken Co Ltd is a leading provider of comprehensive healthcare services, including pharmaceutical distribution, home healthcare, clinical diagnostics, and healthcare IT solutions. The company's commitment to innovation and customer-centric approach has propelled its growth and reputation in the industry. With a strong presence in Japan and expanding globally, Suzuken Co Ltd continues to play a crucial role in shaping the future of healthcare delivery.
Suzuken Co Ltd, a leading stock, has achieved several significant milestones over the years. One milestone is its successful expansion into the global market, establishing a strong presence in various countries. Suzuken has also demonstrated consistent growth through strategic partnerships and mergers, enhancing its product portfolio and market position. Moreover, the company has received recognition for its commitment to innovation and quality, earning prestigious industry awards. Suzuken's consistent financial performance and ability to adapt to evolving market trends further highlight its success as a trusted player in the stock industry. As a result, Suzuken Co Ltd continues to secure its position as a market leader, driving value and growth for its shareholders.
Suzuken Co Ltd is primarily present in Japan.
Suzuken Co Ltd represents values of trust, integrity, and innovation. The company's corporate philosophy is focused on contributing to society through its healthcare business. Suzuken Co Ltd strives to provide high-quality products and services that improve the well-being and health of individuals. With a strong commitment to ethical business practices, Suzuken Co Ltd continually seeks to meet the evolving needs of customers and stakeholders, fostering long-term partnerships built on reliability and excellence. Through its dedication to advancing healthcare solutions, Suzuken Co Ltd aims to create a healthier and more prosperous future for all.
Analyytikot asettavat tällä hetkellä Suzuken Co-osakkeelle keskimääräisen tavoitehinnan 6 303,60 JPY (mediaani: 6 436,20 JPY), mikä merkitsee +117,5 % viimeisimpään hintaan verrattuna. Konsensus perustuu 8 analyytikkoarvioon.
8 analyytikkoa arvioi tällä hetkellä Suzuken Co-osaketta: 4 suosittaa ostoa, 4 pitoa ja 0 myyntiä.
Nykyisellä valuuttakurssilla Suzuken Co-osake noteerataan hintaan 16,44 EUR (2 898,50 JPY).
Suzuken Co-osake (9987.T) on listattuna 3 pörssissä, muun muassa: Tokio (JPX) (9987.T), Hongkong (HKEX) (9987.HK).
Suzuken Co Ltd is a Japanese company specializing in the sale and distribution of pharmaceuticals, medical devices, and diagnostic tests. The company was founded in 1934 and is headquartered in Kyoto, Japan. It operates in various segments, including pharmaceutical supply, medical device trading, diagnostic tests, and other business areas such as health and care products and the Suzuken Pharmacy chain. Suzuken has partnerships with international companies to meet the global demand for its products. It has made acquisitions and partnerships in recent years to expand its business activities and has focused on developing innovative services and technologies. Overall, Suzuken is a key player in the Japanese healthcare industry and is well-positioned to grow and expand its business in the future.
liikevaihto Suzuken Co on 2,49 T JPY. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.
voitto Suzuken Co on 38,14 Mrd. JPY. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.
Suzuken Co:n hinta-voitto-suhde (P/E) on tällä hetkellä 10,23. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Suzuken Co-osakkeen arvostusta.
Suzuken Co:n hinta-myynti-suhde (P/S) on tällä hetkellä 0,16. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Suzuken Co-osakkeen arvostuskennuslukuna.
Suzuken Co:n Eulpool-laatuscore on 2/10.
Suzuken Co:n ISIN on JP3398000004. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
Suzuken Co:n WKN on 914027. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.
Suzuken Co:n ticker on 9987.T. Tämä pörssinoteeraus käytetään Suzuken Co-osakkeiden kauppaan pörssissä.
Suzuken Co osake
Suzuken Co vertaisryhmä
Suzuken Co Ticker
Suzuken Co FIGI
Kaikki tunnusluvut ja syvällinen analyysi Suzuken Co:sta
Meidän osakeanalyysimme Suzuken Co-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Suzuken Co:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: